Search Results
Results found for "Chris Evans"
Posts (50)
- Bell-Evans model and steered molecular dynamics in uncovering the dissociation kinetics of ligands..
October 2022 Bell-Evans model and steered molecular dynamics in uncovering the dissociation kinetics optimized approach of combining the data derived from steered molecular dynamics simulations and the Bell-Evans
- Why Sokhom Pin Never Left GPCRs, Even When Everyone Else Did
But Sokhom Pin stayed loyal to GPCRs , even when big pharma turned its gaze to other targets like kinases
- The Imprecision Problem: Why Your GPCR Drug Discovery Program Is Off-Track Before It Even Starts
But here’s the reality: even ultra-specialized experts can’t fix systemic dysfunction in their spare Even flawless experiments collapse under sloppy systems. data management pipeline, teams waste hours cleaning, reconciling, and integrating before they can even
Other Pages (8)
- Ep 13 with Dr. Amynah Pradhan
Chris Evans at UCLA.
- Ep 95 with Chris Langmead
GPCR Podcast << Back to podcast list Strategic Partners Chris Langmead Chris Langmead is Professor, Deputy Prior to joining Heptares, Chris was a neuroscience researcher at GlaxoSmithKline, UK (1998-2009). Chris serves on the editorial boards of the British Journal of Pharmacology, ACS Chemical Neuroscience
- Ep 32 with Dr. Chris Tate
Chris Tate About this episode Dr. Chris Tate obtained his Ph.D. from the University of Bristol in 1989 and then moved to the University Chris also worked on the E. coli multidrug transporter EmrE and obtained both 2D and 3D crystals as well Join me to learn more about Chris’s work and his role in founding Heptares which was later acquired by Chris Tate on the web LinkedIn ResearchGate Pubmed Google Scholar Sosei Heptares Wikipedia MRC Laboratory
